The post Falling Bitcoin exchange flows is a market red flag appeared on BitcoinEthereumNews.com. Analysts warn that falling Bitcoin exchange activity could makeThe post Falling Bitcoin exchange flows is a market red flag appeared on BitcoinEthereumNews.com. Analysts warn that falling Bitcoin exchange activity could make

Falling Bitcoin exchange flows is a market red flag

For feedback or concerns regarding this content, please contact us at [email protected]

Analysts warn that falling Bitcoin exchange activity could make prices more fragile, even without heavy selling pressure.

Summary

  • Bitcoin exchange flows have dropped, reducing internal market liquidity and increasing sensitivity to sudden trades.
  • Analysts say thin order books and elevated leverage raise the risk of sharp, unstable price moves.
  • Derivatives data shows a reset in speculative positioning rather than panic selling, keeping the market fragile but not broken.

Bitcoin’s price looks calm on the surface, but deeper market mechanics suggest growing fragility beneath the range.

In a Dec. 15 analysis, CryptoQuant contributor XWIN Research Japan warned that a sharp slowdown in Bitcoin (BTC) flows between exchanges is weakening internal market liquidity. This increases the risk of sudden and outsized price moves despite the lack of heavy selling pressure.

Exchange liquidity is quietly drying up

Since the start of December, Bitcoin has chopped sideways between roughly $80,000 and $94,000 after pulling back from its October peak near $126,000. While that range-bound behavior may appear constructive, on-chain data tells a more delicate story.

XWIN pointed to the Inter-Exchange Flow Pulse, a CryptoQuant metric that tracks the flow of Bitcoin between exchanges. The indicator has turned red, indicating a slower flow of capital between trading venues. 

When money flows freely between exchanges, arbitrageurs support deep order books and stable prices. However, liquidity falls when those flows decline. Once momentum builds, even relatively small trades can begin to move prices, increasing slippage and causing sharper swings.

This is unfolding at a time when Bitcoin balances on exchanges are near historic lows. While that can be supportive in quiet markets, since there’s less immediate sell pressure, it also leaves less supply available to cushion sudden buying or selling.

As XWIN notes, the concern isn’t heavy distribution right now, but a fragile market structure. With thinner buffers and leverage still in play, even small shocks can quickly turn into outsized price moves.

Derivatives data points to a reset, not panic

Separate data from another Cryptoquant contributor Arab Chain reinforces the idea that the market is cooling rather than collapsing. The combined open interest and funding Z-score for Binance derivatives metrics is close to -0.28, which is slightly below its historical average. 

That signal indicates that traders are gradually lowering leverage and overall risk rather than jumping into new speculative bets, most likely in response to previous excesses.

In the past, pullbacks often followed sharply positive Z-scores, which typically appeared during overheated runs. The current negative reading tells a different story, one of risk being slowly taken off the table as higher-risk positions are unwound over time.

Bitcoin has largely hovered around the $90,000 level, even as activity in the derivatives market cooled off. There doesn’t seem to be a wave of forced liquidations driving that pullback, but rather traders reducing their leverage.

Although this has somewhat slowed the short-term rally, many analysts see it as a positive reset rather than an indication of more serious weakness. They warn that until exchange liquidity improves, Bitcoin may continue to be susceptible to sudden movements in either direction rather than a steady trend, even though long-term supply dynamics and institutional adoption are still favorable.

Source: https://crypto.news/bitcoin-exchange-flows-decline-market-red-flag-2025/

Market Opportunity
RedStone Logo
RedStone Price(RED)
$0.1313
$0.1313$0.1313
-0.90%
USD
RedStone (RED) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09